Unit 2 : Shri Shankaracharya College of Pharmaceutical Sciences

Achievements

FACULTY ACHIEVEMENTS

• More than 70 research articles are published in national and international journals.
• More than 10 books and 25 book chapters are published by national and international publishers
• More than 30 research outcomes are presented in national and international conferences
• More than 15 patents are published in Indian patent office

STUDENTS ACHIEVEMENTS

• Bhavesh Sahu is a class topper in B. Pharm., Batch 2019-23.
• Alok Yadav is a class topper in D. Pharm., Batch 2019-23
• Bhavesh Sahu got first prize in Pharma-Expo competition on Pharmacist Day
• Aditya Khoshle and groups got first prize in Quiz competition on Pharmacist Day
• Pankaj Ku. Kashyap and Vaishali Verma got prize in Rangoli competition on Pharmacist Day
• Several Students actively participate in Nation Service Scheme (NSS).

Puyblication Metrics

2 Indian patents are granted to Dr. Swarnali Das Paul

• Topical dosage form of apremilast for managing ocular hypertension (Application number: 202011034083, Patent  number: 374314)
• Atazanavir nanocrystal formulation (Application number: 202011038816, Patent number: 393527)

6 patents are published by Dr. Swarnali Das Paul

• Novel delivery system of amfenac
• Colon targeted drug delivery system of anticancer bioactives
• Novel topical formulation with bioflavonoid for kangri cancer
• Nanodelivery system of a chemotherapeutic agent with herbal bioenhancer
• Development of bioflavonoid loaded nanoparticles for anticancer activity
• Formulation and evaluation of diacerin and hesperidine loaded  nanocarrier system for topical use

9 patents are published by Mr. Jhakeshwar Prasad

• A Retroprospective Data analysis of Lung cancer related aspects
• Machine learning based big data analytics of patients suffering from cancer
• A machine learning based approach for early prediction of Neurodegenerative disorder
• Artificial intelligence based approach to analyse the neurological disorder that erupt during Covid-19 Pandemic
• Machine learning based approach to study and analyse the antibacterial effects of silver nanoparticles for healing dental issues
• Artificial intelligence based approach to analyse the therapeutic effect of drugs that are obtained from marine in the treatment of cancer
• Machine learning based approach to predict the various myelosuppression agent can be used along with hydroxyurea in improving the condition of sickle cell anemia
• Artificial intelligence based approach to study the impact of topical nano adjuvants for eradication of skin cancer
• Systematic framework integrated with machine learning approaches for identification and directed delivery of nanoparticles to tumour.

Paper publications in 2022

• 4 Papers are published by Dr. Swarnali Das Paul in international journals
• 3 Papers are published by Dr. Rajesh Choudhary in international journals
• 1 Paper is published by Mrs. Malti Sao in an international journal
• 2 Papers are published by Mr. Jhakeshwar Prasad in international journals
• 1 Paper is published by Mr. Siddharth Kumar Sahu in an international journal

Contact Us

Shri Shankaracharya College of Pharmaceutical Sciences
Shri Shankaracharya Professional University, Bhilai

Reach us on 9977258200, 9827954319
Email us on sscpsbhilai@gmail.com

Rules & Regulation (B. Pharm)

Facilities

• Established in 2019
• Approved by Pharmacy Council of India (PCI), New Delhi
• Affiliated to Chhattisgarh Swami Vivekananda Technical University (CSVTU), Bhilai
• Constituent college under Shri Shankaracharya Professional University (SSPU), Bhilai.
• Qualified Faculties
• Digital Classrooms
• Enlightening and Enriching Academic Ambience
• Equipped Laboratory and Library
• Wi-Fi Campus
• Hi-Tech Audio-Visual Section
• Top notch placements
• Government funded national projects and seminar grants
• More than 15 Indian patents published and granted
• ADR monitoring centre approved by Indian pharmacopeia commission
• Hospital internship facility
• Industrial training and visit programs

Programmes Offered

Contact Us

Shri Shankaracharya College of Pharmaceutical Sciences
Shri Shankaracharya Professional University, Bhilai

Reach us on 9977258200, 9827954319
Email us on sscpsbhilai@gmail.com

SIF Report 2026

AMCs

ADVERSE DRUG REACTION MONITORING CENTRES (Amcs)

The National Coordinating Centre (NCC) - Pharmacovigilance Programme of India (PvPI), Indian Pharmacopoeia Commission (IPC), Ghaziabad has approved Shri Shankaracharya College of Pharmaceutical Sciences (SSCPS), Bhilai as Adverse Drug Reactions Monitoring Centre (AMCs).

Background

The Central Drugs Standard Control Organisation (CDSCO), New Delhi, under the aegis of Ministry of Health & Family Welfare, Government of India has initiated a nation-wide pharmacovigilance programme in July, 2010, with the All India Institute of Medical Sciences (AIIMS), New Delhi as the National Coordinating Centre (NCC) for monitoring Adverse Drug Reactions (ADR) in the country to safe-guard Public Health. In year 2010, 22 ADR monitoring centres (AMCs) including AIIMS, New Delhi had been set up under this Programme. To ensure implementation of this programme in a more effective way, the National Coordinating Centre was then shifted from the All India Institute of Medical Sciences (AIIMS), New Delhi to the Indian Pharmacopoeia Commission (IPC), Ghaziabad, (U.P.) in April, 2011.

The mission of Pharmacovigilance Programme of India (PvPI) is to safeguard the health of the Indian population by ensuring that the benefit of use of medicine outweighs the risks associated with its use. Since there exist considerable social and economic consequences of adverse drug reactions and the positive benefit/cost ratio of implementing appropriate risk management - there is a need to engage healthcare professionals and the public at large, in a well structured programme to build synergies for monitoring adverse drug reactions in the country.

The purpose of the PvPI is to collate data, analyze it and use the inferences to recommend informed regulatory interventions, besides communicating risks to healthcare professionals and the public. The broadened patient safety scope of pharmacovigilance includes the detection of medicines of substandard quality as well as prescribing, dispensing and administration errors. Counterfeiting, antimicrobial resistance, and the need for real time surveillance in mass vaccinations are other pharmacovigilance challenges which need to be addressed.

 Scope and Objectives

·         To create a nation-wide system for patient safety reporting

·         To identify and analyze new signal from the reported cases

·         To analyze the benefit - risk ratio of marketed medications

·         To generate evidence based information on safety of medicines

·         To support regulatory agencies in the decision-making process on use of medications

·         To communicate the safety information on use of medicines to various stakeholders to minimize the risk

·         To emerge as a national centre of excellence for pharmacovigilance activities

·         To collaborate with other national centres for the exchange of information and data management

·         To provide training and consultancy support to other national pharmacovigilance centres across globe

·         To promote rational use of medicine

Contact Us

Shri Shankaracharya College of Pharmaceutical Sciences
Shri Shankaracharya Professional University, Bhilai

Reach us on 9977258200, 9827954319
Email us on sscpsbhilai@gmail.com

Result Analysis

Result Analysis - Academic Session 2023-24

Student Enrolled in Academic Session 2023-24